Stay updated on Clinical Trial: Topical AR100DP1 in AD
Sign up to get notified when there's something new on the Clinical Trial: Topical AR100DP1 in AD page.

Latest updates to the Clinical Trial: Topical AR100DP1 in AD page
- Check7 days agoChange DetectedThe site footer revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check14 days agoChange DetectedThe study record page now displays a 403 Forbidden message and a Home link instead of its study details.SummaryDifference0.5%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the study record content with a minimal error screen that includes a Home link and a site revision note.SummaryDifference20%

- Check49 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6, indicating a small update to the page’s template or backend. This change does not modify the study details or any user-facing content.SummaryDifference0.1%

- Check63 days agoChange DetectedThe Study Documents section now includes the Study Protocol and Statistical Analysis Plan, plus related metadata such as IPD sharing plans and FDA-regulated designations. These additions broaden the available documentation for the study context and compliance information.SummaryDifference59%

- Check70 days agoChange DetectedThe page's revision indicator changed from v3.6.4 to v3.6.5, signaling an updated version of the study details page.SummaryDifference0.1%

Stay in the know with updates to Clinical Trial: Topical AR100DP1 in AD
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Topical AR100DP1 in AD page.